ABOUT US
Founded by a team of experienced Doctors
Dr. Chaitanya, Dr. Swetha & Dr. Sathya the company is built on deep clinical expertise and a strong understanding of real-world surgical needs.
Our Foundation
BUILT TO LAST & HERE TO STAY
VISION
Established in 2023
“Saving lives through advanced and reliable medical solutions”
“Built for speed, compliance, and clinical impact, Zichor combines manufacturing excellence with surgeon-first innovation. Our mission is simple: deliver high-performance surgical products that compete globally—without compromise on quality, safety, or accessibility.”
MEET THE TEAM
Dr. Chaithanya
Managing Director
Dr. Sathyanarayana
Director & CEO
Dr. Swetha
Director & CFO
Rashmi Nair
Chief International Business Officer
S M Narayan
Head of HR
Jayanth Birari
Head of Operation
Raghvendra
Head of Quality
Praveen B
Head of Supply Chain
Arun Kumar
Head of Accounts
Rupesh Shimpi
UI UX & Graphic Designer
MEET THE TEAM
Rashmi Nair
Chief International Business Officer
Jayanth Birari
Head of Operation
Raghvendra
Head of Quality
Praveen B
Head of Supply Chain
Arun Kumar
Head of Accounts
Rupesh Shimpi
UI UX & Graphic Designer
OUR INFRASTRUCTURE
Total Campus
3,50,000 sq. ft
Built Up
25,000 sq. ft
Clean Room
8,000 sq. ft
Class 10,000 (ISO Class 7)
Ensuring strict sterility and biocompatibility essential for medical device manufacturing.
Our facility is equipped with advanced machinery, in-house laboratory and instrumentation setups, and dedicated R&D units. A team of highly skilled and competent professionals ensures precision, consistency, and uncompromised quality in every product we manufacture.
01
100% Clean-Room Manufacturing
02
Analytical Laboratories
03
Inhouse R&D
04
Strong Regulatory Backing
ISO
ISO 13485 Compliant QMS
Our quality management system is built to ISO 13485 the gold standard for medical device quality assurance globally
GMP
Manufacturing Standard
All manufacturing processes adhere to Good Manufacturing Practice guidelines as defined by international regulatory authorities
Compliance
100% Regulatory Compliant
We ensure the facility is compliant with all the regulatory requirements to the highest standard
RESEARCH & DEVELOPMENT
PHASES OF OUR R&D
structured phase-gated development
– In- vitro proof-of-concept through pre-clinical animal models
– Clinical validation in human surgical cases.
Our development process is physician-led at every stage from identifying unmet clinical need through designing study endpoints that reflect what actually matters to a surgeon at the table under pressure.
Research Foundation
SCIENCE FIRST
We collaborate with leading academic medical centers, hemostasis research laboratories, and clinical investigators across India and globally to ensure our science is both cutting-edge and clinically relevant.
No Zichor product reaches commercialization without rigorous, independent evidence of safety and efficacy.
Coagulation-Independent Hemostasis
Developing active hemostatic agents that achieve rapid clot formation independently of the patient's own coagulation cascade enabling effective bleeding control in anticoagulated, thrombocytopenic, and coagulopathic patients.
Topical Bioadhesive Hemostats
Engineering next-generation tissue-adhesive hemostatic dressings with superior wet-surface adhesion, biodegradability, and zero foreign-body reaction for both open and laparoscopic applications.
CERTIFICATION
Certification is not a checkbox it is the foundation of our promise to patients, clinicians, and healthcare systems. We pursue the most rigorous international regulatory standards as a reflection of our commitment to safety and quality.
Our Standards
CERTIFIED TO THE HIGHEST STANDARD
Our certifications span manufacturing quality, product performance, biocompatibility, and sterility covering every dimension of what it means to produce a safe, effective medical device that a surgeon can trust in the most critical moment of a patient's care.
Certification is ongoing, not static. We maintain an active post-market surveillance program and conduct regular internal and external audits to maintain compliance at all times.
ISO 13485:2016
Medical Device Quality Management
Certified
CDSCO Compliant
Central Drugs Standard Control Organization
Certified
CE Marking
European Union Compliance
In Progress
Target: 2026
MDSAP
Medical Device Single Audit Program
In Progress
Target: 2026
Certified
ISO 13485:2016
Medical Device Quality Management
Certified
CDSCO Compliant
Central Drugs Standard Control Organization
In Progress
Target: 2026
CE Marking
European Union Compliance
In Progress
Target: 2026
MDSAP
Medical Device Single Audit Program